| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
| Benazzi F, Mazzoli M |
Psychiatric illness associated with 'ecstasy' |
Lancet |
1991 |
| Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
| Cregg MT, Tracey JA |
Ecstasy abuse in Ireland |
Ir Med J |
1993 |
| McGuire PK, Cope H, Fahy ... |
Diversity of psychopathology associated with use of 3,4-methylenedioxy... |
Br J Psychiatry |
1994 |
| Scheffel U, Dannals RF, S... |
Development of PET/SPECT ligands for the serotonin transporter |
NIDA Res Monogr |
1994 |
| Schifano F, Magni G |
MDMA ('ecstasy') abuse: psychopathological features and craving for ch... |
Biol Psychiatry |
1994 |
| McCann UD, Ricaurte GA |
On the neurotoxicity of MDMA and related amphetamine derivatives [lett... |
J Clin Psychopharmac... |
1995 |
| Cohen RS |
Adverse symptomatology and suicide associated with the use of methylen... |
Biol Psychiatry |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Bitsch A, Thiel A, Rieckm... |
Acute inflammatory CNS disease after MDMA ('ecstasy') |
Eur Neurol |
1996 |
| Curran HV, Travill RA |
Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MD... |
Addiction |
1997 |
| Davison D, Parrott AC |
Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and ... |
Human Psychopharmaco... |
1997 |
| Cohen RS, Cocores J |
Neuropsychiatric manifestations following the use of 3,4-methylenediox... |
Prog Neuropsychophar... |
1997 |
| Capurro A, Reyes-Paroda M... |
Aggressive Behavior and Jamming Avoidance Response in Weakly Electric ... |
Comp Biochem Physiol |
1997 |
| Schifano F, Di Furia L, F... |
MDMA ('ecstasy') consumption in the context of polydrug abuse: a repor... |
Drug Alcohol Depend |
1998 |
| Gerra G, Zaimovic A, Giuc... |
Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('... |
Int Clin Psychopharm... |
1998 |
| Williams A, Segal O, Andr... |
Short gastric artery perforation after use of 'ecstasy' |
J R Soc Med |
1998 |
| Parrott AC, Lasky J |
Ecstasy (MDMA) effects upon mood and cognition: before, during and aft... |
Psychopharmacology (... |
1998 |
| Weinmann W, Bohnert M |
Lethal monointoxication by overdosage of MDEA |
Forensic Sci Int |
1998 |
| Parrott AC, Lees A, Garnh... |
Cognitive performance in recreational users of MDMA of 'ecstasy': evid... |
J Psychopharmacol (O... |
1998 |
| Bailly D |
Neuropsychiatric disorders induced by MDMA ('Ecstasy') |
Encephale |
1999 |
| Hammersley R, Ditton J, S... |
Patterns of ecstasy use by drug users |
British Journal of C... |
1999 |
| Schifano F |
Potential Human Neurotoxicity of MDMA (`Ecstasy'): Subjective Self-Rep... |
Neuropsychobiology |
2000 |
| Pacifici R, Zuccaro P, Fa... |
Immunomodulating activity of MDMA |
Ann N Y Acad Sci |
2000 |
| Shannon M |
Methylenedioxymethamphetamine (MDMA, 'Ecstasy') [In Process Citation] |
Pediatr Emerg Care |
2000 |
| Gamma A, Buck A, Berthold... |
No difference in brain activation during cognitive performance between... |
J Clin Psychopharmac... |
2001 |
| MacInnes, N, Handley, SL ... |
Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... |
J Psychopharmacology |
2001 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Teter CJ, Guthrie SK |
A comprehensive review of MDMA and GHB: two common club drugs |
Pharmacotherapy |
2001 |
| Spitzer M, Franke B, Walt... |
Enantio-selective cognitive and brain activation effects of N-ethyl-3,... |
Neuropharmacology |
2001 |
| Arria AM, Yacoubian GS, F... |
Ecstasy Use Among Club Rave Attendees |
Arch Pediatr Adolesc... |
2002 |
| Verheyden SL, Hadfield J,... |
Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, 'ecst... |
Psychopharmacology (... |
2002 |
| Gurtman CG, Morley KC, Li... |
Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: ass... |
Eur J Pharmacol |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
| Gerra G, Zaimovic A, Moi ... |
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopam... |
Behav Brain Res |
2002 |
| Parrott AC, Buchanan T, S... |
Ecstasy/MDMA attributed problems reported by novice, moderate and heav... |
Hum Psychopharmacol |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| Colbron S, Jones M, Biell... |
MDMA alters the response of the circadian clock to a photic and non-ph... |
Brain Res |
2002 |
| McGregor IS, Gurtman CG, ... |
Increased anxiety and "depressive" symptoms months after MDMA ("ecstas... |
Psychopharmacology (... |
2003 |
| Reijneveld SA, Crone MR, ... |
The effect of a severe disaster on the mental health of adolescents: a... |
Lancet |
2003 |
| Verheyden SL, Henry JA, C... |
Acute, sub-acute and long-term subjective consequences of 'ecstasy' (M... |
Hum Psychopharmacol |
2003 |
| Roiser JP, Sahakian BJ |
Relationship between ecstasy use and depression: a study controlling f... |
Psychopharmacology (... |
2003 |
| Verheyden SL, Maidment R,... |
Quitting ecstasy: an investigation of why people stop taking the drug ... |
J Psychopharmacol |
2003 |
| De Win MM, Reneman L, Rei... |
Mood disorders and serotonin transporter density in ecstasy users-the ... |
Psychopharmacology (... |
2004 |
| Curran HV, Rees H, Hoare ... |
Empathy and aggression: two faces of ecstasy? A study of interpretativ... |
Psychopharmacology (... |
2004 |
| McCardle K, Luebbers S, C... |
Chronic MDMA (ecstasy) use, cognition and mood |
Psychopharmacology (... |
2004 |
| Daumann J, Hensen G, Thim... |
Self-reported psychopathological symptoms in recreational ecstasy (MDM... |
Psychopharmacology (... |
2004 |
| Gahlinger PM |
Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine |
Am Fam Physician |
2004 |
| Milani RM, Parrott AC, Tu... |
Gender differences in self-reported anxiety, depression, and somatizat... |
Addict Behav |
2004 |
| Halpern JH, Pope HG Jr, S... |
Residual neuropsychological effects of illicit 3,4-methylenedioxymetha... |
Drug Alcohol Depend |
2004 |
| Kuypers KP, Ramaekers JG |
Transient memory impairment after acute dose of 75mg 3.4-Methylene-dio... |
J Psychopharmacol |
2005 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
| Heifets BD, Malenka RC |
Disruptive Psychopharmacology |
JAMA Psychiatry |
2019 |
